Comments on: A Phase 1/2 Study to Evaluate the Safety and Efficacy of a Single Dose of Autologous Clustered Regularly Interspaced Short Palindromic Repeats Gene-edited CD34+ Human Hematopoietic Stem and Progenitor Cells (EDIT-301) in Subjects With Severe Sickle Cell Disease https://scdstudies.com/a-phase-1-2-study-to-evaluate-the-safety-and-efficacy-of-a-single-dose-of-autologous-clustered-regularly-interspaced-short-palindromic-repeats-gene-edited-cd34-human-hematopoietic-stem-and-progenitor/?utm_source=rss&utm_medium=rss&utm_campaign=a-phase-1-2-study-to-evaluate-the-safety-and-efficacy-of-a-single-dose-of-autologous-clustered-regularly-interspaced-short-palindromic-repeats-gene-edited-cd34-human-hematopoietic-stem-and-progenitor Thu, 13 Jun 2024 12:21:46 +0000 hourly 1 https://wordpress.org/?v=6.7.1